Pericardial Mesothelioma: A Deadly Subtype


Pericardial Mesothelioma: A Deadly Subtype

I’m Ed Smith, a Sacramento Wrongful Death Lawyer. Most people think of mesothelioma as a type of lung cancer. While this is primarily the case, this doesn’t mean that mesothelioma cannot damage other organs. Some people who have been exposed to asbestos can develop mesothelioma in the linings of their heart, a subtype of the disease called pericardial mesothelioma.

How Does Mesothelioma Spread to the Heart?

Pericardial Mesothelioma: A Deadly Subtype syndicated from

Mass Tort Lawsuit Filed over Eliquis for Causing Fatal Internal Bleeding

The estate administrators for a New York man filed a product liability suit against Briston-Myers Squibb Co. and Pfizer Inc., charging that their drug blood-thinning drug Eliquis caused the internal bleeding that killed him.

Raymond Warme of East Hampton, NY, was prescribed Eliquis in April 2014 for atrial fibrillation. Within two months he began having gastrointestinal bleeding which led to his death.

The case, Dawn Dunn et al. v. Briston-Myers Squibb Co., case No. 156043/2017, is filed in New York Supreme Court. The plaintiffs are his daughter Dawn Dunn and his significant other Orla Troy.

In parallel mass tort litigation, 69 cases have been filed since February 2017 in the Southern District of New York before Sr. US District Judge Denise L. Cote in MDL 2754, In Re Eliquis (Apixaban) Products Liability Litigation.

Fraud and deceit by Big Pharma companies

The New York lawsuit says, “These representations were made by defendants with the intent of defrauding and deceiving decedent, the public in general, and the medical and healthcare community including decedent’s prescribing doctor, and were made with the intent of inducing [them] to recommend, dispense and purchase Eliquis, all of which evinced a callous, reckless, willful, depraved indifference to health, safety, and welfare of the decedent herein.”

Bristol-Myers and Pfizer’s wrongdoing started in 2010 with the Aristotle clinical study, calculated to get the drug approved by the FDA. During that study, the companies concealed side effects and didn’t report a death, subjects dropping out and dispensing errors, the complaint states.

Employees of the drugmakers also wrote an article published on Aug. 28, 2011, in the New England Journal of Medicine based on the study which the editor-in-chief found to be inaccurate and containing omissions, the suit says.

The FDA said on Feb. 9, 2012, that the companies showed “a pattern of inadequate supervision” and the agency pressed to get more information during the approval process, saying data was missing. The agency also said the label should mention the quality-control issues in the study, according to the suit.

On Dec. 28, 2012, the FDA approved Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation.

“Defendants overstated the efficacy of Eliquis with respect to preventing stroke and systemic embolism, failed to adequately disclose to patients that there is no drug, agent, or means to reverse the anticoagulation effects of Eliquis and that such irreversibility would have life-threatening and fatal consequences,” the suit says.

Two years later in 2014, more than 1,000 adverse event reports were filed with the FDA in that year alone, including at least 100 deaths, and more than 6,000 adverse event reports in 2015 consisting of hemorrhaging / gastrointestinal hemorrhaging. Yet the companies never strengthened their label.

Mass Tort Lawsuit Filed over Eliquis for Causing Fatal Internal Bleeding syndicated from

Early Rehabilitation is Vital for Recovery

File:Patient on balance board for rehabilitation.jpg

Early Rehabilitation is Vital for Recovery

I’m Ed Smith, a Sacramento Brain Injury Lawyer. Neurological injuries continue to challenge modern society in more ways than one. When a patient or a loved one has suffered a traumatic brain injury, the immediate aftermath can be overwhelming for everyone involved. While it can be a challenge to remain focused, it is important for any rehabilitation following a brain injury to begin as rapidly as possible.

Early Recovery Backed Up by Research

Early Rehabilitation is Vital for Recovery syndicated from

South Lake Tahoe Head-On Collision Hospitalizes 3

Head-on collision

South Lake Tahoe Head-On Collision Hospitalizes 3

I’m Ed Smith, a South Lake Tahoe Car Accident Lawyer. Seven people were involved in a head-on collision in South Lake Tahoe that sent three to the hospital on Thursday, July 13.

What Happened?

South Lake Tahoe Head-On Collision Hospitalizes 3 syndicated from

New Biomarker Could be Used for Concussion Treatment

New Biomarker Could be Used for Concussion Treatment

New Biomarker Could be Used for Concussion Treatment

I’m Ed Smith, a Sacramento Brain Injury Lawyer. Because of the attention that accidents and professional sports have brought to the world of concussions, a significant amount of funding has been poured into this area of research. Fortunately, this funding is starting to show fruit, particularly with a recent research study on biomarkers. A new discovery could change the way that concussions are diagnosed, monitored, and treatment that could mean an increase in the quality of life of patients everywhere.

A Novel Approach for a Crisis

New Biomarker Could be Used for Concussion Treatment syndicated from